Literature DB >> 35128853

Novel vaginoplasty technique involving the use of peritoneal flaps during laparoscopic radical hysterectomy for early-stage cervical cancer.

Iori Kisu1,2, Miho Iida3, Tetsuro Shiraishi3, Kouji Banno3.   

Abstract

Radical hysterectomy is often performed to treat early-stage cervical cancer in women of reproductive age, and sexual dysfunction due to postoperative vaginal shortening is a major concern [1,2]. Vaginoplasty using various techniques is commonly performed in patients with congenital vaginal agenesis [3]. However, there are few reports of vaginoplasty being performed for vaginal shortening after radical hysterectomy in a patient with cervical cancer [4,5]. We demonstrate a novel vaginoplasty technique in which peritoneal flaps are used during laparoscopic radical hysterectomy to prevent postoperative vaginal shortening and consequent sexual dysfunction in patients with early-stage cervical cancer. A 37-year-old woman with early-stage cervical cancer who wished to perform sexual activity postoperatively underwent laparoscopic radical hysterectomy and vaginoplasty. After radical hysterectomy, the residual vaginal length was 4 cm. The dissected peritoneum of pouch of Douglas (posterior peritoneal flap) was sutured to the posterior vaginal stump. The supravesical peritoneum was dissected from the ventral to the dorsal side to create an anterior peritoneal flap, which was inverted, pulled down, and sutured to the anterior vaginal stump. The anterior peritoneal flap and suprarectal peritoneum were sutured to create a 10-cm neovaginal vault. Subsequently, a methacrylic resin mold was inserted into the neovagina to prevent postoperative neovaginal stenosis. The patient had sexual intercourse 3 months postoperatively. She was satisfied with the sexual activity and experienced no vaginal shortening or stenosis. Our novel vaginoplasty technique is feasible and effective for preventing sexual dysfunction by lengthening the vagina during laparoscopic radical hysterectomy for early-stage cervical cancer. Trial Registration: Japan Registry of Clinical Trials Identifier: jRCT1030210227.
Copyright © 2022. Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology, and Japan Society of Gynecologic Oncology.

Entities:  

Keywords:  Cervical Cancer; Hysterectomy; Laparoscopy; Surgical Procedures, Operative; Vagina

Mesh:

Year:  2022        PMID: 35128853      PMCID: PMC8899872          DOI: 10.3802/jgo.2022.33.e19

Source DB:  PubMed          Journal:  J Gynecol Oncol        ISSN: 2005-0380            Impact factor:   4.401


  5 in total

1.  Vaginal changes and sexuality in women with a history of cervical cancer.

Authors:  K Bergmark; E Avall-Lundqvist; P W Dickman; L Henningsohn; G Steineck
Journal:  N Engl J Med       Date:  1999-05-06       Impact factor: 91.245

2.  A Simple Laparoscopic Procedure to Restore a Normal Vaginal Length After Colpohysterectomy With Large Upper Colpectomy for Cervical and/or Vaginal Neoplasia.

Authors:  Eric Leblanc; Lucie Bresson; Benjamin Merlot; Marco Puga; Frederic Kridelka; Audrey Tsunoda; Fabrice Narducci
Journal:  J Minim Invasive Gynecol       Date:  2015-08-20       Impact factor: 4.137

3.  Early cervical cancer impact of peritoneal vaginoplasty combined with laparoscopic radical hysterectomy improved sexual function.

Authors:  Shu-Qin Chen; Ling-Zhi Kong; Hong-Ye Jiang; Li Fan; Jun Chen; Shu-Zhong Yao
Journal:  Int J Gynecol Cancer       Date:  2015-03       Impact factor: 3.437

Review 4.  An update on surgical and non-surgical treatments for vaginal hypoplasia.

Authors:  Nina Callens; Griet De Cuypere; Petra De Sutter; Stan Monstrey; Steven Weyers; Piet Hoebeke; Martine Cools
Journal:  Hum Reprod Update       Date:  2014-06-03       Impact factor: 15.610

5.  Early-stage cervical carcinoma, radical hysterectomy, and sexual function. A longitudinal study.

Authors:  Pernille T Jensen; Mogens Groenvold; Marianne C Klee; Ingrid Thranov; Morten Aa Petersen; David Machin
Journal:  Cancer       Date:  2004-01-01       Impact factor: 6.860

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.